188975-47-5

Basic information

• Product Name: DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate
• Synonyms: DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate;2-(2-fluoro-4-nitrophenyl)Propanedioic acid 1,3-dimethyl ester
• CAS NO: 188975-47-5
• Molecular Formula: C₁₁H₁₀FNO₆
• Molecular Weight: 271.1986032
• Mol File: 188975-47-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate(CAS DataBase Reference)
• NIST Chemistry Reference: DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate(188975-47-5)
• EPA Substance Registry System: DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate(188975-47-5)

Safety Data

• Hazardous Substances Data: 188975-47-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate is used as a building block for the synthesis of various biologically active molecules. Its malonic ester structure allows for the formation of diverse chemical entities through various synthetic routes.
Used in Pharmaceutical Research:
DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate is used as a starting material for the production of agrochemicals and pharmaceuticals. Its unique properties enable the development of new drugs with potential therapeutic applications.
Used in Fluorescent Probes:
DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate has shown potential as a fluorescent probe for detecting biological molecules. Its fluorescent properties can be utilized for the identification and analysis of various biomolecules in research settings.
Used in Antimicrobial Applications:
DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate has been studied for its potential antimicrobial properties. Its ability to target and inhibit the growth of microorganisms makes it a promising candidate for the development of new antimicrobial agents.
Used in Anticancer Research:
DiMethyl 2-(2-Fluoro-4-nitrophenyl)Malonate has been investigated for its potential anticancer properties. Its unique structure and reactivity may contribute to the development of novel anticancer drugs with improved efficacy and selectivity.

Upstream product

• 108-59-8 malonic acid dimethyl ester 
• 185331-69-5 1-bromo-2-fluoro-4-nitrobenzene 
• 369-34-6 3,4-difluoronitrobenzene 

Downstream Products

• 1160623-38-0 ethyl 2-(2-fluoro-4-nitrophenyl)acetate 
• 1146975-25-8 Dimethyl 2-(2-cyanoethyl)-2-(2-fluoro-4-nitrophenyl)malonate 
• 1402585-91-4 dimethyl 2-(2-fluoro-4-nitrophenyl)-2-methylmalonate 
• 1402585-94-7 phenyl 4-(1,3-dihydroxy-2-methylpropan-2-yl)-3-fluorophenylcarbamate 
• 1402585-93-6 2-(4-amino-2-fluorophenyl)-2-methylpropane-1,3-diol 
• 1402585-92-5 2-(2-fluoro-4-nitrophenyl)-2-methylpropane-1,3-diol 
• 1402585-88-9 dimethyl 2-(4-amino-2-fluorophenyl)malonate 
• 1402585-89-0 dimethyl 2-(2-fluoro-4-(phenoxycarbonylamino)phenyl)malonate 
• 1402585-90-3 phenyl 4-(1,3-dihydroxypropan-2-yl)-3-fluorophenylcarbamate 
• 1221119-68-1 2-(2-fluoro-4-nitrophenyl)ethan-1-ol 
• 1402586-84-8 phenyl 3-fluoro-4-(2-hydroxyethyl)phenylcarbamate 
• 1402581-65-0 1-[[5-tert-butyl-2-(3-chlorophenyl)-2H-pyrazol-3-yl]methyl]-3-[3-fluoro-4-[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]phenyl]urea 
• 1402581-63-8 1-[[2-(3-chlorophenyl)-5-(trifluoromethyl)-2H-pyrazol-3-yl]methyl]-3-[3-fluoro-4-[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]phenyl]urea 
• 1402581-62-7 1-[[2-(3-chlorophenyl)-5-(trifluoromethyl)-2H-pyrazol-3-yl]methyl]-3-[3-fluoro-4-[2-hydroxy-1-(hydroxymethyl)ethyl]phenyl]urea 

Relevant articles and documents

SUBSTITUTED PYRAZOLYL-BASED CARBOXAMIDE AND UREA DERIVATIVES BEARING A PHENYL MOIETY SUBSTITUTED WITH AN O-CONTAINING GROUP AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives of formula (Q) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF

Disclosed are substituted thioimidazolidinone compounds and pharmaceutical compositions comprising such compounds. The compounds and compositions can be used for treatment of androgen receptor-associated diseases or disorders, such as prostate cancer, benign prostatic hypertrophy, male hair loss and hypertrichosis.

DIARYLHYDANTOIN COMPOUNDS

The present invention relates to diarylhydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Substituted Phenylamino-Pyrimidines

The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.

SUBSTITUTED PHENYLAMINO-PYRIMIDINES

The invention relates to substituted phenylamino-pyrimidines, to a method for their production and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular for the treatment of cardiovascular diseases.